Symphony Financial’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,239
Closed -$518K 292
2025
Q3
$518K Buy
+4,239
New +$526K 0.06% 160
2022
Q1
Sell
-1,630
Closed -$285K 198
2021
Q4
$285K Sell
1,630
-6,364
-80% -$1.06M 0.08% 157
2021
Q3
$1.34M Buy
7,994
+336
+4% +$57.9K 0.47% 46
2021
Q2
$1.38M Buy
+7,658
New +$1.4M 0.47% 46
2020
Q4
Sell
-1,072
Closed -$225K 154
2020
Q3
$225K Sell
1,072
-37
-3% -$8.24K 0.09% 127
2020
Q2
$243K Sell
1,109
-146
-12% -$29.2K 0.12% 121
2020
Q1
$219K Buy
+1,255
New +$207K 0.15% 85

Other funds holding CLX

Symphony Financial's CLX Position: Q4 2025 in Review

Symphony Financial sold out of Clorox (CLX) in Q4 2025, closing a stake of 4,239 shares — an estimated $518K sold.

Symphony Financial first reported a position in CLX in Q1 2020 and held it in 7 quarters. The position peaked at $1.38M in Q2 2021. 1,051 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Symphony Financial reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Symphony Financial sold 4,239 Clorox shares in Q4 2025, an estimated $518K.
  • Symphony Financial first reported a position in Clorox in Q1 2020 and held it in 7 quarters.
  • Symphony Financial's Clorox position peaked at $1.38M in Q2 2021.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Symphony Financial's 13F filing for Q4 2025, filed 11 Feb 2026.